EPIRUS Biopharmaceuticals (EPRSQ) Stock Price, News & Analysis

Company Overview

EPIRUS Biopharmaceuticals, Inc. was a biotechnology company focused on developing and commercializing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to previously approved reference medicines and are intended to expand patient access to complex therapies while potentially reducing treatment costs.

The company’s activities centered on building a portfolio of biosimilar product candidates for use in areas such as autoimmune and inflammatory diseases. EPIRUS pursued global development and commercialization opportunities through partnerships and other strategic arrangements, although publicly available information about its product pipeline and commercial operations is limited.

EPIRUS Biopharmaceuticals’ common stock traded under the symbol EPRSQ on the over-the-counter market. The company subsequently entered financial restructuring proceedings, and its current operating status, leadership, product development activities and geographic presence are not clearly documented in reliable publicly available sources.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 8/20/2014
• Today: 9/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:EPRSQ
• Previous Symbol: NASDAQ:EPRS
• CIK: 1135906
• Web: www.epirusbiopharma.com
• Phone: (617) 600-3497
• Fax: 617-301-7010
• Employees: 70
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A